Tempus AI Time Trial Network8 Mar 2026 11:37
Guess Avacta Ruairidh Edwards : Associate Director, Clinical Science & Translational Medicine | Clinical Science & Biomarkers in Oncology team have a key data role identifying patient selection . - advantage of using new AI tools .
------------------------
Ruairidh Edwards likes this
Tempus AITempus AI
123,505 followers123,505 followers
1d • 1 day ago • Visible to anyone on or off LinkedIn
Follow
For life sciences companies, the journey from a promising compound to a first-in-human study is filled with operational hurdles that can delay timelines and inflate cost. To address these challenges, Tempus developed the TIME Trial Network, a program designed to accelerate trial activation and enrollment.
A new case study details how sponsors are leveraging the Tempus TIME Trial Network to launch Phase 1 studies more efficiently, reaching critical milestones faster. Read here: https://tempus.co/4aTxMSf
------------
"The TIME Network has significantly impacted the enrollment of patients in Phase 1 oncology trials by streamlining the activation and enrollment process. By leveraging a nationwide network of clinical sites optimized for rapid study start-up, the TIME Network has enabled sponsors to accelerate trial activation and enrollment, which is crucial for generating early clinical data and securing further investment. The network's Just-in-Time activation model allows sites to be activated in as little as 30 business days before identifying the first eligible patient, significantly reducing the time to enrollment. This approach has been instrumental in achieving faster trial timelines and improving overall study quality, as seen in the case of TriHealth, which achieved a 64% annual increase in patients enrolled in clinical trials with the TIME program. "
Gmcc
Sign In
Follow the stocks
